Cardiff Oncology, Inc.CRDFNASDAQ
Loading
Net Debt Over TimeElevated
Percentile Rank43
Studio
Year-over-Year Change

Total debt minus cash and cash equivalents

Latest
$-16.64M
↑ 42% vs avg
Percentile
P43
Within normal range
Streak
1 yr
Consecutive growthElevated
Average
$-28.68M
Historical baseline
PeriodValueYoY Change
2025$-16.64M+66.7%
2024$-49.95M-156.1%
2023$-19.51M-43.1%
2022$-13.63M-54.5%
2021$-8.82M+93.2%
2020$-130.11M-1436.3%
2019$-8.47M+26.1%
2018$-11.45M-66.1%
2017$-6.89M+67.7%
2016$-21.36M-